Just Because a Drug is FDA Approved Doesn't Mean it Works

The video is the final episode in a series on drug approval in the U.S., discussing the FDA's standards, controversies like Adjihelm, and the Right to Try Act. It explores differing opinions on whether the FDA is too risk-averse or lenient, highlighting issues like increased clinical trial costs and the opioid crisis. The video concludes with a preference for the FDA's expanded access over the Right to Try Act, emphasizing the need for verifying clinical efficacy post-approval.

What new insight or understanding did you gain from this video?